GE HealthCare's True Definition DL, a deep learning-based CT image reconstruction tool, has received FDA 510(k) clearance.
Key Details
- 1True Definition DL is a deep learning CT image reconstruction solution from GE HealthCare.
- 2The AI tool increases image resolution without requiring workflow or protocol changes.
- 3It improves visualization of fine anatomical structures such as small airways and pulmonary nodules.
- 4Designed to avoid longer scan times and higher radiation doses typically needed for detailed images.
- 5Available for both field CT upgrades and new installations on the Revolution Apex and Revolution Vibe platforms.
- 6Adds to GE’s portfolio of cleared DL-based imaging solutions, including TrueFidelity DL and True Enhance DL.
Why It Matters
FDA clearance of True Definition DL may enhance the adoption of deep learning reconstruction in CT imaging, potentially leading to better diagnostic confidence and outcomes with greater efficiency. This underscores the expanding role of AI in everyday radiology workflows.
Source
Radiology Business
Related News
•AuntMinnie
AI-Based Slab Reconstruction Streamlines Digital Breast Tomosynthesis
AI-driven slab reconstruction in DBT improves workflow efficiency without compromising diagnostic accuracy in breast cancer screening.
•AuntMinnie
AI Model Predicts Dosimetry for Lu-177 PSMA Therapy Using PET/CT
A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
•Radiology Business
DeepHealth's Prostate AI Gains FDA Clearance for MRI Workflows
DeepHealth, a RadNet subsidiary, received FDA clearance for its AI solution to assist prostate cancer detection and MRI workflow.